[Analysis of relative factors of restenosis after artificially grafting bypasses on chronic ischemia of lower extremities].
OBJECTIVE
To analyze the relative factors of early-term restenosis after artificially grafting bypasses on chronic ischemia of lower extremities.


METHODS
From January 2006 to September 2007, 40 cases suffered from chronic ischemia of lower extremities were treated by single side femoropopliteal bypass were followed up during 6 months after operation. There were 36 male and 4 case female with a mean age of (66 +/- 9) years old. Lipid, fibrinogen (FIB) and hypersensitive C reactive protein (hsCRP) were chemical examined during peri-operation. Basing on the degree of restenosis in vascular anastomosis by Color Doppler graft scan, all the patients were divided into light, moderate and severe groups, respectively. Biochemical indicators and cytokines were investigated such as lipid, FIB, hsCRP, IL-6, transforming growing factor beta1 (TGF-beta1). Possible risk factors resulting in restenosis were compared statistically among three groups with SPSS 15.0.


RESULTS
Restenosis were more severe among the patients with concomitance disease such as diabetes mellitus and smoking after operation. Relative risk were 6.47 and 7.92, respectively. There are significant difference in total cholesterin, low density lipoprotein, FIB, hsCRP, IL-6 and TGF-beta1 among three groups during six months after operation (P < 0.05). Multiple linear regression showed that FIB and TGF-beta1 may be the risk factors to intimal hyperplasia.


CONCLUSIONS
Diabetes mellitus, smoking and higher levels of FIB may be the major high risk factors resulting in neointima hyperplasia and anastomosis restenosis.
Zhao
Ke-qiang
KQ
Department of Vascular Surgery, Beijing Military General Hospital, Beijing 100700, China. zkqiang@yahoo.com.cn
Yu
Jian
J
Guo
Qing-xu
QX
Zhang
Xiao-ming
XM
D000368:Aged; D019917:Blood Vessel Prosthesis Implantation; D002097:C-Reactive Protein / Q000032:analysis; D002908:Chronic Disease; D048909:Diabetes Complications; D005260:Female; D005340:Fibrinogen / Q000032:analysis*; D006083:Graft Occlusion, Vascular / Q000209:etiology*; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D007511:Ischemia / Q000097:blood / Q000601:surgery*; D035002:Lower Extremity / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors; D012907:Smoking; D053773:Transforming Growth Factor beta1 / Q000097:blood
C508600:IL6 protein, human; D015850:Interleukin-6; D053773:Transforming Growth Factor beta1; D005340:Fibrinogen; D002097:C-Reactive Protein